Imtiaz Lone
Senior Research Scientist
Affiliation: NYU Abu Dhabi
Education: PhD ENS Lyon
Research Areas: CRISPR-Cas9 genome engineering, Chromatin biology, Stem cell and disease modeling, Genetics, Epigenetics
Imtiaz Lone is a chromatin biologist with more than twelve years of experience in chromatin biochemistry, epigenetics, genome engineering, and stem cell-based disease modeling. He completed his doctoral training at the École Normale Supérieure de Lyon, France, where he investigated the structural and biochemical mechanisms underlying NF-κB–nucleosome interactions. He subsequently joined EMBL Heidelberg, Germany, as an EMBL Postdoctoral Fellow in the Genome Biology Unit, where he worked in the laboratory of Eileen Furlong and developed novel locus-specific chromatin proteomics approaches to investigate long-range enhancer–promoter interactions.
Before joining NYU Abu Dhabi, Lone led a research team at the Izmir Biomedicine and Genome Centre, Turkey, where his research focused on understanding the molecular mechanisms underlying rare neurodevelopmental chromatinopathies, particularly Rahman syndrome. His work combined CRISPR-engineered stem cell models, multi-omics approaches, and chromatin interactome mapping to investigate how alterations in chromatin regulation contribute to disease. His research has been published in Nature Communications, Molecular Cell, Genome Biology, and PLOS Genetics.
At NYU Abu Dhabi, Lone applies his expertise in chromatin engineering, CRISPR/Cas9 genome editing, and functional genomics to the development of genetic tools and the study of gene regulation. His broader research interests focus on understanding how epigenetic mechanisms regulate genome function, cell identity, and adaptation.